GEHC
GE HealthCare Technologies Inc
GE HealthCare Technologies Inc historical holders
total: 6
Trian Fund Management GE HealthCare Technologies Inc transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2023 Q1
- Held for:
- 13 quarters
- Latest activity:
- 2025 Q4
Nelson Peltz has been an institutional investor in GE HealthCare Technologies Inc (GEHC) since 2023 Q1. According to 2026 Q1 report, Nelson Peltz holds 4,044 shares with a market value of roughly $287.85K representing 0.01% of their equity portfolio. The fund/company first acquired GEHC in 2023 Q1, initially purchasing about 1.34M shares. Since the initial investment, Trian Fund Management has made 3 more transactions in this position.
Does Nelson Peltz still hold GEHC?
Yes, Nelson Peltz continues to hold GE HealthCare Technologies Inc (GEHC). According to their 2026 Q1 report, they maintain a position of 4,044 shares valued at approximately $287.85K, representing 0.01% of their equity portfolio.
When did Nelson Peltz first invest in GEHC?
Nelson Peltz first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q1 at the reported quarter-end price of $82.03 per share, acquiring 1,342,830 shares in their initial purchase.
What is Nelson Peltz's average cost basis for GEHC?
Based on historical transaction data, Nelson Peltz's estimated cost basis for GE HealthCare Technologies Inc (GEHC) is approximately $82.03 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $82.03
- Weighted AVG sell price:
- $93.85
GEHC transactions history by Trian Fund Management
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
0.01%
|
4,044
|
$82.02
|
$331,689
|
+0.37% (+15)
|
+0%
|
|
2024 Q3
|
0.01%
|
4,029
|
$93.85
|
$378,122
|
-99.70% (-1,338,804)
|
-3.06%
|
|
2023 Q4
|
1.48%
|
1,342,833
|
$77.32
|
$103,827,848
|
+0.00% (+3)
|
+0%
|
|
2023 Q1
|
2.94%
|
1,342,830
|
$82.03
|
$110,152,345
|
new
|
+2.94%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.